Pubblicazioni

Human estrogen receptor Î± antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants

2022 - EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Kurtanovic, N.; Tomasevic, N.; Matic, S.; Mitrovic, M. M.; Kostic, D. A.; Sabatino, M.; Antonini, L.; Ragno, R.; Mladenovic, M.

Targeting endothelin-1 receptor/ÃÂ²-arrestin1 network for the treatment of ovarian cancer

2017 - EXPERT OPINION ON THERAPEUTIC TARGETS

RosanÃ£Â², Laura; Cianfrocca, Roberta; Sestito, Rosanna; Tocci, Piera; Di Castro, Valeriana; Bagnato, Anna

Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes

2017 - BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Musumeci, Domenica; Amato, Jussara; Zizza, Pasquale; Platella, Chiara; Cosconati, Sandro; Cingolani, Chiara; Biroccio, Annamaria; Novellino, Ettore; Randazzo, Antonio; Giancola, Concetta; Pagano, Bruno; Montesarchio, Daniela

An overview of early investigational therapies for chemoresistant ovarian cancer

2015 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Marchetti, Claudia; Ledermann, Jonathan A.; BENEDETTI PANICI, Pierluigi

Pubblicazioni

Human estrogen receptor Î± antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants

Targeting endothelin-1 receptor/ÃÂ²-arrestin1 network for the treatment of ovarian cancer

Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes

An overview of early investigational therapies for chemoresistant ovarian cancer

Targeting endothelin-1 receptor/ÃÂ²-arrestin1 network for the treatment of ovarian cancer